Novartis Aktie

126,70 EUR -0,55 EUR -0,43 %

08:03:12

STU

126,56 EUR -1,36 EUR -1,06 %

07:34:40

HAML

Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.241,57 Mrd. EUR

KGV18,30Div. Rendite3,38%

WKN904278

ISINCH0012005267

SymbolNVSEF

Novartis Aktien News

Sortieren:Datum Meistgelesen

23.03.26Dow JonesPress Release: Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026

20.03.26ZacksNovartis Strikes $3B Oncology Deal for Breast Cancer Asset

20.03.26BenzingaNovartis Strikes $3 Billion Deal For Next-Gen Breast Cancer Drug

WerbungNovartis-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

20.03.26Dow JonesPress Release: Novartis agrees to acquire a pan-mutant-selective PI3KALPHA> inhibitor, strengthening its breast cancer pipeline

16.03.26BenzingaNovartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients

13.03.26Dow JonesPress Release: Novartis Cosentyx(R) receives FDA -2-

13.03.26Dow JonesPress Release: Novartis Cosentyx(R) receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa

09.03.26BenzingaWhat Analysts Are Saying About Alcon Stock

05.03.26BenzingaAlcon Earnings Report: Q4 Overview

02.03.26ZacksIs Alcon (ALC) Stock Outpacing Its Medical Peers This Year?

02.03.26BenzingaWhat's Driving the Market Sentiment Around Novartis AG?

28.02.26BenzingaSecond HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement

27.02.26Dow JonesPress Release: Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

27.02.26Dow JonesPress Release: Novartis receives positive CHMP -2-

27.02.26Dow JonesPress Release: Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU)

25.02.26ZacksWhy Alcon (ALC) is a Top Growth Stock for the Long-Term

25.02.26MotleyFoolAlcon (ALC) Q4 2025 Earnings Call Transcript

25.02.26Dow JonesPress Release: Novartis to build new radioligand therapy site in Denton, Texas, delivering more next--generation treatments to patients

25.02.26ZacksAlcon (ALC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

24.02.26MotleyFoolCould Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?

24.02.26Dow JonesPress Release: Novartis: New real--world data -2-

24.02.26Dow JonesPress Release: Novartis: New real--world data reinforce earlier use of Pluvicto(TM) before chemotherapy in metastatic castration-resistant prostate cancer

23.02.26BenzingaEarnings Preview: Alcon

23.02.26Dow JonesPress Release: Novartis presents Rhapsido(R) (remibrutinib) data at AAAAI, showing potential beyond chronic spontaneous urticaria (CSU)

22.02.26MotleyFoolNovartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for Decades

19.02.26ZacksGear Up for Alcon (ALC) Q4 Earnings: Wall Street Estimates for Key Metrics

18.02.26Dow JonesPress Release: Novartis remibrutinib first -2-

18.02.26Dow JonesPress Release: Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)

17.02.26BenzingaA Look Into Novartis Inc's Price Over Earnings

13.02.26BenzingaNovartis Says Conditionally Approved Kidney Drug Shows Long-Term Promise

13.02.26Dow JonesPress Release: Novartis Vanrafia(R) Phase III -2-

13.02.26Dow JonesPress Release: Novartis Vanrafia(R) Phase III data support slowing of kidney function decline in patients with IgA nephropathy

06.02.26Dow JonesPress Release: Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

05.02.26MotleyFoolNovartis (NVS) Q3 2024 Earnings Call Transcript

04.02.26BenzingaNovartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead

04.02.26ZacksNovartis Beats on Q4 Earnings, Entresto Generics Pressure Sales

04.02.26ZacksNovartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

04.02.26Dow JonesPress Release: Novartis delivered high -5-

04.02.26Dow JonesPress Release: Novartis delivered high -4-

Novartis News

Novartis News: auf dieser Seite finden Sie alle Novartis News und Nachrichten zur Novartis Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novartis News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novartis News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.